| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $235.1M | -18.8% |
| R&D Expense | $58.4M | -13.8% |
| SG&A Expense | $45.9M | -0.6% |
| Operating Income | -$23.9M | +27.2% |
| Pre-tax Income | -$26.7M | +2.2% |
| Income Tax | $1.9M | +38.5% |
| Net Income | -$28.6M | +0.2% |
| EPS (Basic) | -$0.23 | -4.5% |
| EPS (Diluted) | -$0.23 | -4.5% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $104.9M | -3.9% |
| Current Assets | $134.8M | -8.4% |
| Total Assets | $290.6M | -10.0% |
| Current Liabilities | $43.2M | -12.6% |
| Total Liabilities | $62.8M | -19.8% |
| Stockholders' Equity | $227.9M | -6.9% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $26.3M | -42.4% |
| Capital Expenditures | $968K | -75.7% |
| Investing Cash Flow | -$16.9M | +35.7% |
| Financing Cash Flow | -$14.9M | +64.4% |
| Free Cash Flow | $25.4M | -39.2% |